FDA official logo
GSRS logoPFDA official logo

VOFATAMAB

UNII:JMH6YR91PG
Formula:
Preferred Substance Name:VOFATAMAB

  • 1312305-12-6
  • ANTI-FGFR3 MONOCLONAL ANTIBODY MFGR1877S
  • ANTI-FGR3
  • B701
  • B-701
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR TYPE 3) (HUMAN MONOCLONAL MFGR1877S HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MFGR1877S .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FGFR3 (FIBROBLAST GROWTH FACTOR RECEPTOR 3, CD333)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN (1-457) (VH (HOMO SAPIENS IGHV3-66*01 (85.7%)-(IGHD)-IGHJ4*01 (100%)) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (224) (128-225), HINGE (226-240), CH2 (241-350), CH3 E12 (366), M14 (368) (351-455), CHS (456-457)) (128-457)), (230-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-5*01 (86.7%)-IGKJ1*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (236-236'':239-239'')-BISDISULFIDE
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR-3, ANTIGEN CD333))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-457) (HOMO SAPIENS VH (IGHV3-66*01 (86%) (IGHD)-IGHJ4*01) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(224))) (128-457)) (230-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-5*01 (87%) IGKJ1*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (236-236'':239-239'')-BISDISULFIDE
  • MFGR 1877S [WHO-DD]
  • MFGR1877A
  • MFGR-1877A
  • MFGR1877S
  • MFGR-1877S
  • RECOMBINANT HUMAN IGG1 KAPPA ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 3 MONOCLONAL ANTIBODY B-701
  • RG7444
  • RG-7444
  • VOFATAMAB [INN]
  • VOFATAMAB [USAN]
  • VOFATAMAB [WHO-DD]




UNII - JMH6YR91PG | UNII Search Service